Latest Blogs

Guest Commentary
Feb 23, 2021
The Road Ahead: Using Common Language to Improve Patient Understanding, Communication, and Uptake of Cancer Testing
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
Anne Katz, PhD, RN, FAAN
Feb 18, 2021
Attending an Appointment Alone in the Time of COVID
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Guest Commentary
Feb 11, 2021
“Speak Better”: Stripes and Swipes of a Global Language
"My motto is to stand up for all the people who face casual racism, sexism, and injustice, and my aim is to protect international trainees in medicine when it is my turn to be a mentor," Dr. Viju Chandrasekhar affirms as she shares a personal experience with bias based on her accent.
Inas Abuali, MD, FACP
Feb 11, 2021
Fellows as Teachers: Paying It Forward
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Mar 11, 2019
Losing a Board Member: 5 Lessons From the Life of Dr. Arti Hurria
For many of us not a day has gone by without some reminder of Arti, but last week brought it all back into sharp focus as I was asked to talk about the role we at ASCO played in her career during a symposium in her honor.
Feb 07, 2019
Exclusive Interview: FDA Commissioner Dr. Scott Gottlieb Talks Drug Pricing, Expanded Access, and Tobacco Control
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Feb 01, 2019
Reflections on World Cancer Day 2019: The Challenge of “I Will”
What will each of us do, going forward, to further confront and reduce the global burden of cancer? For us at ASCO, the challenge will be answered through our mission pillars: education, research, and quality.
Jan 28, 2019
What You Need to Know About the Final 2019 Medicare Physician Fee Schedule and Quality Payment Program Rule
Editor’s note: Dr. Hudis hosts the ASCO in Action Podcast, which focuses on policy and practice issues affecting providers and patients. An excerpt of a recent episode is shared below; it has been edited for length and clarity.
Jan 14, 2019
A Conversation With Dr. Beverly Moy: Removing Financial Barriers to Clinical Trials Participation
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Oct 03, 2018
Medicaid Work Requirements: A Conversation With Dr. Manali Patel
The chair-elect of the ASCO Health Equity Committee and I discuss concerns with proposed Medicaid work requirements and their impact on patients with cancer and their physicians.

Pages